Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

Renal failure

Not recruiting

Investigational

Study of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Rmc-035

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Investigational

Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Small cell lung cancer limited stage

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Investigational

Study on the Effects and Safety of Ladarixin for Adults and Adolescents with Recent Onset Type 1 Diabetes

Investigational

Germany

Participants:0–17 years · 18–64 years
Substances:Ladarixin

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Investigational

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Inupadenant Hydrochloride

Contact Research Centre

Squamous cell carcinoma of the oral cavity+3

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Find therapies in clinical trials near you – page 14

245 trials match your criteria

Plasma cell myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Renal failure

Study of RMC-035 to prevent kidney injury in patients undergoing open-chest heart surgery

Gastrooesophageal cancer

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Malignant melanoma

Study of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery

Squamous cell carcinoma of head and neck

Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

Pulmonary arterial hypertension

Study of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality

Small cell lung cancer limited stage

Study on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer

Type 1 diabetes mellitus

Study on the Effects and Safety of Ladarixin for Adults and Adolescents with Recent Onset Type 1 Diabetes

Pulmonary hypertension

Study on Sotatercept for Treating Pulmonary Hypertension in Adults with Heart Failure

Non-small cell lung cancer metastatic

Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

Squamous cell carcinoma of the oral cavity+3

Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.